BCL2 and idiopathic pulmonary fibrosis: Hence, in the present study, we sought to explore whether Bcl-2 is a promising target for IPF and evaluate the antifibrotic effect of ABT-199 on BLM-induced pulmonary inflammation and lung fibrosis.